Insight

Kinetic Profiling

Sep 6, 2024, 09:54

Kinetic Profiling of RAS Mutations With Circulating Tumor DNA Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient

JCO Precision Oncology made the following post on X:

“Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient.”

Authors: Florence T.H. Wu, James T. Topham, Chris J. O’Callaghan, Harriet Feilotter, Hagen F. Kennecke, Leylah Drusbosky, Daniel J. Renouf, Derek J. Jonker, Dongsheng Tu, Eric X. Chen, Jonathan M. Loree.

Source: JCO Precision Oncology/X

Canadian Cancer Trials Group CO.26 Trial cancer Chris J. O'Callaghan Circulating tumor DNA Daniel J Renouf Derek J. Jonker Dongsheng Tu Eric X. Chen Florence T.H. Wu Hagen F.Kennecke Harriet Feilotter James T. Topham Jonathan M. Loree Leylah Drusbosky Metastatic colorectal cancer OncoDaily Oncology RAS mutations

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 10

OncoThon 2024 Raises $1.3 Million for Pediatric Cancer Research

Richard Sullivan: Do we need a 'new' Geneva Convention and protocols?

Remembering Virgil Abloh: Louis Vuitton’s Creative Director Honored at 41 After His Brave Battle with Cardiac Angiosarcoma

Special Coverage